Our research team is focussed on investigating infection in chronic lung disease. We are currently focussed on determining the contribution of the many microbes present in the lung, to development of disease and exacerbation in cystic fibrosis, COPD and bronchiectasis. Projects currently ongoing in our lab range from determining the effect of cigarette smoke and electronic cigarette vapour on the key lung pathogens, investigating the significance of MRSA infection in the lungs of people with CF and developing novel outcome measures for assessing antimicrobial efficacy in the CF lung.